Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.

doi:10.1016/j.cmet.2016.09.013

Paper

Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.

Published Dec 13, 2016 · K. Mills, Shohei Yoshida, L. Stein

Cell metabolism

Q1 SJR score

634

Citations

29

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Animal Study

Rigorous Journal

Highly Cited

Study Snapshot

Long-term nicotinamide mononucleotide administration effectively mitigates age-associated physiological decline in mice, improving energy metabolism, insulin sensitivity, and eye function without harm.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.

References

Citations